Aitor Nogales-Gonzalez

Title: Aitor Nogales-Gonzalez: Innovator in Canine Influenza Research

Introduction

Aitor Nogales-Gonzalez is a prominent inventor based in Rochester, NY (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for canine influenza virus. With a total of 4 patents to his name, his work is pivotal in advancing the treatment and prevention of this viral infection.

Latest Patents

Aitor's latest patents include innovative approaches to combat canine influenza virus. One of his notable inventions is a live-attenuated vaccine that incorporates mutations in the viral polymerase. This invention focuses on the treatment and prevention of canine influenza virus (CIV) and related pathologies. It is based on the discovery that specific mutations in segments 1 and 2 of the CIV genome, which encode mutant PB2 and PB1 proteins, render the virus temperature-sensitive. Another significant patent involves an NS1 truncated virus aimed at developing canine influenza vaccines. This invention also targets the treatment and prevention of CIV and is based on the development of mutant CIV with mutations in segment 8, which induces a CIV-specific immune response in subjects.

Career Highlights

Aitor has worked with esteemed institutions such as the University of Rochester and Cornell University. His research has been instrumental in enhancing the understanding of canine influenza and developing effective vaccines.

Collaborations

Aitor has collaborated with notable colleagues in his field, including Luis Martinez-Sobrido and Colin Parrish. Their combined expertise has contributed to the advancement of research in canine influenza.

Conclusion

Aitor Nogales-Gonzalez is a key figure in the fight against canine influenza, with his innovative patents paving the way for effective treatments and vaccines. His work continues to impact veterinary medicine positively.